These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2062607)

  • 41. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study.
    Kalra V; Chaudhry R; Dua T; Dhawan B; Sahu JK; Mridula B
    J Child Neurol; 2009 Jun; 24(6):664-8. PubMed ID: 19491112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II.
    Hartung HP; Pollard JD; Harvey GK; Toyka KV
    Muscle Nerve; 1995 Feb; 18(2):154-64. PubMed ID: 7823973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between Campylobacter infection and Guillain-Barré syndrome.
    Allos BM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
    Engberg J; Nachamkin I; Fussing V; McKhann GM; Griffin JW; Piffaretti JC; Nielsen EM; Gerner-Smidt P
    J Infect Dis; 2001 Jul; 184(2):215-20. PubMed ID: 11400076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain-Barré syndrome.
    Gruenewald R; Ropper AH; Lior H; Chan J; Lee R; Molinaro VS
    Arch Neurol; 1991 Oct; 48(10):1080-2. PubMed ID: 1929902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
    Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
    Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
    Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
    J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current concepts in Guillain-Barré syndrome.
    Franco DA; Bashir RM
    Nebr Med J; 1996 Dec; 81(12):406-11. PubMed ID: 9046790
    [No Abstract]   [Full Text] [Related]  

  • 50. Campylobacter jejuni infection and the Guillain-Barre syndrome: mechanisms and implications.
    Allos BM; Blaser MJ
    Zentralbl Bakteriol; 1994 Nov; 281(4):544-8. PubMed ID: 7727903
    [No Abstract]   [Full Text] [Related]  

  • 51. [Guillain-Barré syndrome associated Campylobacter jejuni serogroup Penner A showing antecedent fever and abdominal pain without diarrhea].
    Fukushima T; Yukawa T; Makino K; Matsubara N; Yamazaki M
    No To Shinkei; 2005 Oct; 57(10):889-92. PubMed ID: 16277234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Advances in the research on the pathogenic role of Campylobacter jejuni in Guillain-Barre syndrome].
    Tang J; Yuan JM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):375-7. PubMed ID: 1305004
    [No Abstract]   [Full Text] [Related]  

  • 53. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Campylobacter jejuni infection and Guillain-Barre syndrome.
    Aguago JM; Ramos JT; Lumbreras C
    N Engl J Med; 1996 Mar; 334(12):802. PubMed ID: 8592566
    [No Abstract]   [Full Text] [Related]  

  • 55. Are Campylobacter curvus and Campylobacter upsaliensis antecedent infectious agents in Guillain-Barré and Fisher's syndromes?
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neurol Sci; 1999 Feb; 163(1):53-7. PubMed ID: 10223411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
    Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
    No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of axonal form of Guillain-Barré syndrome associated with anti-GM1b IgG antibody following Penner 4 Campylobacter jejuni infection].
    Nagayama S; Kurohara K; Matsui M; Kuroda Y; Kusunoki S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):506-8. PubMed ID: 9366179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Campylobacter jejuni infection in patient with Guillain-Barré syndrome: a case report].
    Kopyta I; Wardak S
    Med Dosw Mikrobiol; 2008; 60(1):59-63. PubMed ID: 18634345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Campylobacter jejuni HS:23 and Guillain-Barre syndrome, Bangladesh.
    Islam Z; van Belkum A; Cody AJ; Tabor H; Jacobs BC; Talukder KA; Endtz HP
    Emerg Infect Dis; 2009 Aug; 15(8):1315-7. PubMed ID: 19751603
    [No Abstract]   [Full Text] [Related]  

  • 60. Guillain-Barré syndrome and Campylobacter infection.
    Isaäcson M
    J Travel Med; 1998 Sep; 5(3):160. PubMed ID: 9882164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.